Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Jul;11(7):812-22.
doi: 10.2174/138945010791320809.

Potential of plant-derived natural products in the treatment of leukemia and lymphoma

David M Lucas  1 , Patrick C Still, Lynette Bueno Pérez, Michael R Grever, A Douglas Kinghorn
Affiliations
Review

Potential of plant-derived natural products in the treatment of leukemia and lymphoma

David M Lucas et al. Curr Drug Targets. 2010 Jul.

Abstract

Hematologic malignancies account for a substantial percentage of cancers worldwide, and the heterogeneity and biological characteristics of leukemias and lymphomas present unique therapeutic challenges. Although treatment options exist for most of these diseases, many types remain incurable and the emergence of drug resistance is pervasive. Thus, novel treatment approaches are essential to improve outcome. Nearly half of the agents used in cancer therapy today are either natural products or derivatives of natural products. The enormous chemical diversity in nature, coupled with millennia of biological selection, has generated a vast and underexplored reservoir of unique chemical structures with biologic activity. This review will describe the investigation and application of natural products derived from higher plants in the treatment of leukemia and lymphoma and the rationale behind these efforts. In addition to the approved vinca alkaloids and the epipodophyllotoxin derivatives, a number of other plant compounds have shown promise in clinical trials and in preclinical investigations. In particular, we will focus on the discovery and biological evaluation of the plant-derived agent silvestrol, which shows potential for additional development as a new therapeutic agent for B-cell malignancies including chronic lymphocytic leukemia.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest statement The authors have no conflicts of interest to disclose.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009. CA Cancer J Clin. 2009;59:225–249. - PubMed
    1. Kinghorn AD. In: Foye’s Principles of Medicinal Chemistry. Lemke T, Williams DA, editors. Baltimore: Wolters Kluwer/Lippincott Williams & Wilkins; 2008. pp. 12–25.
    1. Williams DH, Stone MJ, Hauck PR, Rahman SK. Why are secondary metabolites (natural products) biosynthesized? J Nat Prod. 1989;52:1189–1208. - PubMed
    1. Noble RL. Vincaleukoblastine. Can Med Assoc J. 1961;85:610–611. - PMC - PubMed
    1. Noble RL, Beer CT, Cutts JH. Further biological studies of vincaleukoblastine – an alkaloid isolated from Vinca rosea (L.) Biochem. Pharmacol. 1958;1:347–348.

Publication types

MeSH terms